Acute hepatitis delta virus infection in Italy: Incidence and risk factors after the introduction of the universal anti-hepatitis B vaccination campaign

被引:34
作者
Mele, Alfonso
Mariano, Andrea
Tosti, Maria Elena
Stroffolini, Tommaso
Pizzuti, Renato
Gallo, Giovanni
Ragni, Pietro
Zotti, Carla
Lopalco, Pierluigi
Curtale, Filippo
Balocchini, Emanuela
Spada, Enea
机构
[1] Ist Super Sanita, Natl Ctr Epidemiol Surveillance & Hlth Promot, Clin Epidemiol Unit, I-00162 Rome, Italy
[2] San Giacomo Hosp, Gastroenterol Unit, Rome, Italy
[3] Publ Hlth Agcy Lazio Reg, Rome, Italy
[4] Reg Hlth Author, Naples, Italy
[5] Serv Publ Hlth & Hyg, Unita Locale Socio Sanit 1, Treviso, Italy
[6] Reg Hlth Author, Bologna, Italy
[7] Univ Turin, Dept Publ Hlth & Microbiol, Turin, Italy
[8] Univ Bari, Inst Hyg, Bari, Italy
[9] Reg Hlth Author, Florence, Italy
关键词
D O I
10.1086/510433
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Updates on the incidence of and risk factors for acute hepatitis delta virus infection in Italy, as well as in other countries, are lacking, and the impact of the mandatory anti - hepatitis B vaccination has not been evaluated. Methods. We performed a case- control study within a population- based surveillance for acute viral hepatitis. Results. During 1993 - 2004, 344 cases of acute hepatitis delta virus infection were reported. After a peak in 1993 ( 2.8 cases per 1 million population), the incidence decreased from 1.7 to 0.5 cases per 1 million population. Coinfections were prevalent. The decrease in incidence particularly affected young adults, and it paralleled the decrease in incidence of acute hepatitis B. In 1993, being an injection drug user ( adjusted odds ratio [ OR adj], 67.9; 95% confidence interval [ CI], 18.1 - 254.5) or being a member of a household with a carrier of hepatitis B surface antigen ( OR adj, 14.8; 95% CI, 3.0 - 72.9) were the only independent predictors of infection. During 1994 - 2004, being an injection drug user ( ORadj, 36.8; 95% CI, 20.7 - 65.4), cohabitation with an injection drug user ( OR adj, 4.2, 95% CI, 1.7 - 12.3), hospitalization ( ORadj, 3.5; 95% CI, 1.9 - 6.6), receipt of dental therapy ( ORadj, 2.3; 95% CI, 1.4 - 3.6), promiscuous sexual activity ( ORadj, 2.2; 95% CI, 1.4 - 3.6), and receipt of beauty treatment ( ORadj, 2.0; 95% CI, 1.3 - 3.2) were independently associated with infection. Conclusions. Incidence of acute hepatitis delta infection is markedly decreasing in Italy. Undergoing invasive medical procedures, engaging in promiscuous sexual activity, and receiving beauty treatments are emerging, in addition to injection drug use, as important risk factors for infection. Further efforts are needed to increase vaccine coverage in high- risk groups and to implement the safety of invasive procedures performed both inside and outside health care facilities.
引用
收藏
页码:E17 / E24
页数:8
相关论文
共 23 条
[1]   Risk factors for hepatitis B in an outbreak of hepatitis B and D among injection drug users [J].
Bialek, SR ;
Bower, WA ;
Mottram, K ;
Purchase, D ;
Nakano, T ;
Nainan, O ;
Williams, IT ;
Bell, BP .
JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 2005, 82 (03) :468-478
[2]   CHANGING EPIDEMIOLOGY OF HEPATITIS-B IN ITALY - PUBLIC-HEALTH IMPLICATIONS [J].
DAMELIO, R ;
MATRICARDI, PM ;
BISELLI, R ;
STROFFOLINI, T ;
MELE, A ;
SPADA, E ;
CHIONNE, P ;
RAPICETTA, M ;
FERRIGNO, L ;
PASQUINI, P .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1992, 135 (09) :1012-1018
[3]   Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B [J].
Fattovich, G ;
Giustina, G ;
Christensen, E ;
Pantalena, M ;
Zagni, I ;
Realdi, G ;
Schalm, SW .
GUT, 2000, 46 (03) :420-426
[4]   Chronic hepatitis D: A vanishing disease? An Italian multicenter study [J].
Gaeta, GB ;
Stroffolini, T ;
Chiaramonte, M ;
Ascione, T ;
Stornaiuolo, G ;
Lobello, S ;
Sagnelli, E ;
Brunetto, MR ;
Rizzetto, M .
HEPATOLOGY, 2000, 32 (04) :824-827
[5]  
Hadziyannis S J, 1993, Prog Clin Biol Res, V382, P259
[6]   Hepatitis delta - Review [J].
Hadziyannis, SJ .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1997, 12 (04) :289-298
[7]   Role of beauty treatment in the spread of parenterally transmitted hepatitis viruses in Italy [J].
Mariano, A ;
Mele, A ;
Tosti, ME ;
Parlato, A ;
Gallo, G ;
Ragni, P ;
Zotti, C ;
Lopalco, P ;
Pompa, MG ;
Graziani, G ;
Stroffolini, T .
JOURNAL OF MEDICAL VIROLOGY, 2004, 74 (02) :216-220
[8]  
MELE A, 1986, European Journal of Epidemiology, V2, P300, DOI 10.1007/BF00419494
[9]   Hepatitis B in Italy: Where we are ten years after the introduction of mass vaccination [J].
Mele, A ;
Stroffolini, T ;
Zanetti, AR .
JOURNAL OF MEDICAL VIROLOGY, 2002, 67 (03) :440-443
[10]   Risk of parenterally transmitted hepatitis following exposure to surgery or other invasive procedures: results from the hepatitis surveillance system in Italy [J].
Mele, A ;
Spada, E ;
Sagliocca, L ;
Ragni, P ;
Tosti, ME ;
Gallo, G ;
Moiraghi, A ;
Balocchini, E ;
Sangalli, M ;
Lopalco, PL ;
Stroffolini, T .
JOURNAL OF HEPATOLOGY, 2001, 35 (02) :284-289